首页> 美国卫生研究院文献>The Journal of Experimental Medicine >Human lymphoma mutations reveal CARD11 as the switch between self-antigen–induced B cell death or proliferation and autoantibody production
【2h】

Human lymphoma mutations reveal CARD11 as the switch between self-antigen–induced B cell death or proliferation and autoantibody production

机译:人类淋巴瘤突变揭示出CARD11是自身抗原诱导的B细胞死亡或增殖与自身抗体产生之间的转换

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Self-tolerance and immunity are actively acquired in parallel through a poorly understood ability of antigen receptors to switch between signaling death or proliferation of antigen-binding lymphocytes in different contexts. It is not known whether this tolerance-immunity switch requires global rewiring of the signaling apparatus or if it can arise from a single molecular change. By introducing individual CARD11 mutations found in human lymphomas into antigen-activated mature B lymphocytes in mice, we find here that lymphoma-derived CARD11 mutations switch the effect of self-antigen from inducing B cell death into T cell–independent proliferation, Blimp1-mediated plasmablast differentiation, and autoantibody secretion. Our findings demonstrate that regulation of CARD11 signaling is a critical switch governing the decision between death and proliferation in antigen-stimulated mature B cells and that mutations in this switch represent a powerful initiator for aberrant B cell responses in vivo.
机译:通过对抗原受体在不同情况下信号转导死亡或抗原结合淋巴细胞增殖之间切换的能力了解不足,可以并行地主动获得自我耐受和免疫。尚不知道这种耐受性-免疫开关是否需要对信号装置进行整体重新布线,或者是否可能由单个分子变化引起。通过将人类淋巴瘤中发现的单个CARD11突变引入小鼠的抗原激活的成熟B淋巴细胞中,我们在这里发现,淋巴瘤衍生的CARD11突变将自身抗原的作用从诱导B细胞死亡转变为不依赖T细胞的增殖,由Blimp1介导。成浆细胞分化和自身抗体分泌。我们的发现表明,CARD11信号的调控是决定抗原刺激的成熟B细胞死亡和增殖之间决定的关键开关,并且该开关中的突变代表体内异常B细胞反应的有力引发剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号